Cyclo Therapeutics (NASDAQ:CYTH) Stock, Quote.Headers.trade-ideas

Cyclo Therapeutics

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

hersheys-6492925_1280

News

Downgrades

Markets

Analyst Ratings

Trading Ideas

CYTH

Citigourp Global Markets 2% Protected Notes Linked To The Djia

This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Titoli a dividendo scelti dai migliori analisti di Wall Street

Earnings

Equities

Eurozone

Commodities

AIRI

OBLG

PTON

REVB

RZLV

Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results

Dubai_gold_market

Intraday Update

Gold Down Over 1%; US Initial Jobless Claims Increase

Cyclo Therapeutics Inc

WIIM

Exelon shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a price target of $46. Also, UBS raised its price target from $40 to $43.

Scotiabank analyst Andres Coello maintains Telefonica Brasil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>) with a Sector Perform and raises the price target from $9.2 to $10.4.

Price Target

Scotiabank Maintains Sector Perform on Telefonica Brasil, Raises Price Target to $10.4

JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) with a Market Outperform and maintains $7 price target.

Reiteration

RZLT

JMP Securities Reiterates Market Outperform on Rezolute, Maintains $7 Price Target

Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) has outperformed the market over the past 5 years by 11.6% on an annualized basis producing an average annual return of 25.48%. Currently, Spotify Technology has a market capitalization of $72.95 billion. 
Buying $1000 In SPOT: If an investor had bought $1000 of SPOT stock 5 years ago, it would be worth $2,987.17 today based on a price of $363.27 for SPOT at the time of writing.
<h3>Spotify Technology's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726842619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPOT

$1000 Invested In Spotify Technology 5 Years Ago Would Be Worth This Much Today

Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) has outperformed the market over the past 5 years by 30.87% on an annualized basis producing an average annual return of 44.75%. Currently, Arista Networks has a market capitalization of $118.82 billion. 
Buying $100 In ANET: If an investor had bought $100 of ANET stock 5 years ago, it would be worth $628.39 today based on a price of $378.21 for ANET at the time of writing.
<h3>Arista Networks's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726842614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANET

If You Invested $100 In This Stock 5 Years Ago, You Would Have $600 Today

Investors are showing strong confidence in Sam Altman-led OpenAI as the company seeks to raise $5 billion or more in its latest funding round. 
What Happened: The San Francisco-based start-up, backed by Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is finalizing a new fundraising round that values the company at $150 billion. Thrive Capital, led by Josh Kushner, has already invested at least $1 billion in recent weeks, according to sources familiar with the deal, Financial Times <a href="https://www.ft.com/content/a8f9bd05-0999-415d-af86-c73e79ad5733">reported</a> on Friday.
"We're talking about the path to building a trillion-dollar company," a partner at an investment backing OpenAI said. 
Another investor revealed that while the stakes are high, the ChatGPT maker has a dominant position both as an enterprise and among the consumer base.
&#8220;This type of business tends to be ‘winner takes most': you're not going to have two ChatGPTs on your phone," the investor added.
See Also: <a href="https://www.benzinga.com/news/24/09/40892284/oracles-larry-ellison-predicts-police-officers-will-be-supervised-at-all-times-and-citizens-will-be?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Oracle&#8217;s Larry Ellison Predicts Police Officers Will Be Supervised &#8216;At All Times&#8217; And Citizens Will Be On Their Best Behavior Thanks To Constant AI-Powered Surveillance</a> 
However, some leading tech investors are also opting out of this round, according to sources. Concerns about achieving venture-style returns on such a large investment have been raised by some investors.
Why It Matters: The valuation of $150 billion for OpenAI hinges on <a href="https://www.benzinga.com/news/24/09/40864744/openais-150b-valuation-hinges-on-whether-sam-altman-led-ai-startup-can-remove-profit-cap-for-investo">significant corporate changes</a>, including the removal of a profit cap for investors. This shift from a research-based non-profit to a more investment-attractive entity aims to support its pursuit of artificial general intelligence (AGI).
In August, <a href="https://www.benzinga.com/news/24/08/40636153/apple-in-talks-to-invest-in-openai-as-chatgpt-makers-valuation-climbs-to-100b-report">Apple and Nvidia </a>were reportedly in talks to invest in OpenAI, as the company&#8217;s valuation climbed to $100 billion. This interest from major tech companies underscores the growing importance of artificial intelligence in the tech industry.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40812318/samsung-to-reportedly-slash-global-workforce-by-up-to-30-in-certain-divisions-amid-intense-competiti?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Samsung To Reportedly Slash Global Workforce By Up To 30% In Certain Divisions Amid Intense Competition From Apple, Huawei</a></li>
</ul>
Image Credits &#8211; Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Startups

Tech

General

MSFT

Investors Bet OpenAI Is On The Path To 'Building A Trillion-Dollar Company' As Sam Altman-Led ChatGPT Maker Aims To Raise $5B And More In Upcoming Funding Round

Tenon Medical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares are trading higher by 21.3% to $6.10 during Friday&#8217;s session after the company announced the issuance of three notices of allowance for <a href="https://www.benzinga.com/pressreleases/24/09/ac40947422/tenon-medical-announces-issuance-of-three-notices-of-allowance-for-patent-applications-from-the-u">patent applications</a> from the UPSTO.
What To Know: These patents cover innovations related to SI joint prostheses, including drug delivery systems that aids bone growth and new designs to address failed SI joint stabilizations. 
The company says the patents, expected to be granted within 90 days, will bolster Tenon Medical's patent portfolio, which includes nine previously issued U.S. and international patents, along with 26 pending applications.
What Else: According to Tenon Medical&#8217;s CTO Richard Ginn, the company&#8217;s growing intellectual property portfolio plays a key role in its strategy to expand the commercialization of its Catamaran SI Joint Fusion System. 
Tenon has also recently filed additional patent applications, supporting its efforts to offer improved solutions for SI joint stabilization.
Read Also: <a href="https://www.benzinga.com/government/24/09/40946073/no-privacy-for-profits-sake-ftc-calls-out-amazon-meta-big-tech-for-exposing-users-to-host-of-harms">No Privacy For Profit&#8217;s Sake: FTC Calls Out Amazon, Meta, Big Tech For Exposing Users To &#8216;Host Of Harms&#8217;</a>
<h2 class="wp-block-heading">How To Buy TNON Stock</h2>
By now you're likely curious about how to participate in the market for Tenon Medical &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline. According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, TNON has a 52-week high of $37.60 and a 52-week low of $2.80.

TNON

Why Tenon Medical (TNON) Stock Is Skyrocketing Friday

Good Morning Traders! In today&#39;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#39;s pulse to optimize your trading gains. Now, let&#39;s dive into the stock analysis:
<h3>SPDR S&amp;P 500 ETF Trust</h3>
SPY is currently moving around the critical level of 567.81. For bullish momentum to gain traction, we&#39;d like to see a push higher toward 569.16. A sustained move above this level could signal that buyers are stepping in, with a potential drive towards 569.98. If this level is maintained during the trading session, we could see a further move upward toward 571.06. Should buying momentum persist, the high bull target for the day stands at 572.15.
However, if 567.81 fails to hold as support, we expect bears to target 566.46. If selling intensifies, a deeper move down to 565.38 is possible. Should this level break, we could see the price testing the stronger support at 564.29. In the event of a strong sell-off, the low bear target for SPY could reach 563.23.
<h3>Invesco QQQ Trust Series 1</h3>
QQQ is trading around the crucial level of 481.73. For bulls to remain in control, we&#39;d like to see the price stay above this support level, with an initial target of 483.95. If buyers are able to hold this level, a further push toward 486.10 may be in play. Continued bullish strength could bring 487.69 into focus, with a high bull target for the day at 490.05.
If 481.73 breaks down as support, sellers may look to push the price lower to 479.03. A failure at this level could lead to a test of 476.85, with bears aiming to break down further toward 474.66. Should selling pressure remain strong, we could see the low bear target of 471.33 being tested during today&#39;s session.
<h3>Apple Inc. </h3>
Apple is trading near the 227.82 level. Bulls will want to see this support hold, targeting an initial move up to 229.03. If this level is reclaimed, we expect continued bullish action to drive the price toward 230.25. A strong bullish run could result in Apple testing higher at the high bull target of 231.76 for the day.
If 227.82 cannot sustain itself as support, bears will likely drive the price down to 226.90. If further selling occurs, Apple may see a drop to 226.08. With sustained downside pressure, the price could fall to 225.31, with a low bear target for the day at 223.87.
<h3>Microsoft Corp</h3>
Microsoft is auctioning around the key level of 437.10. If bulls manage to defend this level, they may push the price toward 438.72. A successful break and hold above this level could propel the stock toward 441.34. Continued bullish momentum may take the stock higher, with a high bull target for the day at 442.95.
If 437.10 fails to hold, bears could gain control, targeting 435.79. If this level breaks, we may see further downside action to 434.49. With continued selling pressure, bears could push Microsoft to the low bear target of 431.25 for the day.
<h3>NVIDIA Corporation</h3>
NVIDIA is currently hovering near 116.61. If the bulls can hold this level, we may see a move toward 117.86, with buyers aiming to reclaim this as a solid support. If successful, the price could rise further to 119.44. Strong bullish sentiment could drive the stock toward the high bull target of 121.97.
If 116.61 fails to hold, sellers will likely look to test the next support at 115.83. A break below this level could see NVIDIA drop further to 115.15, with continued downside momentum potentially driving the price to 114.29. If the selling pressure persists, the low bear target for the day stands at 113.68.
<h3>Alphabet Inc Class A </h3>
Alphabet is currently trading around 161.79. Bulls need to defend this level and push the price towards 163.79. Continued buying pressure could drive the price to 165.41, which is the high bull target for the day.
If 161.79 fails as support, the bears will likely aim to push the price down to 160.36. A breakdown here could see the price drop to 158.54, and in the event of strong selling, we could see a move towards the low bear target of 157.41.
<h3>Meta Platforms Inc </h3>
Meta is currently auctioning around 559.29. Bulls need to hold this level to initiate a move higher to 565.53. A strong bullish advance could push Meta to 573.25, with continued strength potentially reaching the high bull target of 585.73.
If 559.29 fails to hold as support, bears may step in to target 553.05. If selling pressure intensifies, the price could drop to 548.44. If the downside persists, Meta could reach its low bear target of 541.79 for the day.
<h3>Tesla Inc. </h3>
Tesla is trading around 242.49. Bulls will want to see the price rise to 243.98, with strong buying activity driving the price toward 246.16. If the broader market supports a bullish move, we could see Tesla testing 248.37, with a high bull target at 250.25.
If 242.49 fails to hold as support, bears may push the price lower to 239.92. If selling pressure continues, Tesla could test 238.50. Should this level break, the low bear target for the day sits at 235.74.
Final Word: Today&rsquo;s trading session lacks any major U.S. economic data, providing a quiet backdrop for market activity. However, traders should be mindful of potential volatility due to Triple Witching Friday, where stock options, stock index futures, and stock index options expire simultaneously, which can lead to abrupt price movements. Additionally, remarks from Fed&#39;s Harker at 1 PM ET could give insight into monetary policy, while the SEMI Billings Report at 6 PM ET may provide an industry-specific outlook for semiconductor sales. Stay vigilant, trade cautiously, and use today as an opportunity to capitalize on the potential volatility while managing risk effectively. Happy Friday, and good luck!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day&mdash;hours before it&#39;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Market Clubhouse Morning Memo - September 20th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)

Scotiabank analyst Andres Coello maintains America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) with a Sector Perform and lowers the price target from $18.9 to $17.8.

Scotiabank Maintains Sector Perform on America Movil, Lowers Price Target to $17.8

Green Dot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gdot#NYSE">GDOT</a>) is currently focusing on long-term growth through prepaid cards, BaaS partnerships, and a strong balance sheet amid some challenges, including a decrease in customers and the end of partnerships in its traditional consumer division and its Banking-as-a-Service (BaaS) sector.
<h2>Factors That Bode Well</h2>
Green Dot remains focused on ensuring the&nbsp;long-term growth of its businesses. The company&#39;s efforts are toward the acquisition of long-term users by issuing prepaid cards both under its brand, sold in stores, and through co-branded cards like the Walmart Money Card.
<div class="chart_embed">
<h2>Green Dot Corporation Revenue</h2>
<h2><img alt="greendotcorprevenue.jpg" src="https://www.benzinga.com/files/u1593113/greendotcorprevenue.jpg" style="height:307px; width:636px" /></h2>
Green Dot Corporation revenue-ttm | Green Dot Corporation Quote
In addition to its core offerings like prepaid cards and tax processing services, Green Dot utilizes its technology and FDIC-insured banking license to provide &quot;Banking-as-a-Service.&quot; This essentially involves Green Dot offering white-label banking products to large corporations such as Walmart, Uber, and Apple.
</div>
In return for delivering these financial products, the company gains access to a substantial customer base from these global firms, many of which have large and loyal customer followings. Once these customers adopt banking products powered by Green Dot, the company can generate revenues through interchange fees when customers use their debit cards and by retaining deposits, which generate additional interest income. Green Dot has a unique position among banks offering Banking-as-a-Service.
This uniqueness stems from its asset-light balance sheet, which allows for higher interchange rates and reduces its reliance on interest income as a revenue source. This approach keeps the company&#39;s balance sheet efficient and allows Banking-as-a-Service to remain significant and profitable.
Green Dot has a strong balance sheet with&nbsp;no debt obligations.Cash and equivalents were $1.38 billion as of June 30, 2024. During 2023, the company generated an operating cash flow of $98 million. In the second quarter of 2024, it generated an operating cash flow of $31 million. Since the company carries no debt, the cash is available for investments in growth initiatives and distribution to shareholders.
<h2>Some Risks</h2>
The company is facing some challenges. A decrease in customers, coupled with the&nbsp;end of key partnerships&nbsp;in its traditional consumer division and its Banking-as-a-Service (BaaS) sector, directly affected its revenue streams. As customer numbers dwindle, so does the transactional activity that contributes to GDOT&#39;s income. Additionally, the loss of partnerships, particularly in BaaS, undermines their business model, which depends on collaborating with other firms to offer integrated banking services.
Green Dot has never declared and currently&nbsp;does not have any plan to pay cash dividends&nbsp;on common stock. The Federal Reserve Board&#39;s risk-based and leverage capital requirements and other federal laws restrict the company&#39;s ability to pay cash dividends. Investors seeking cash dividends may avoid buying Green Dot&#39;s shares.
<h2>Zacks Rank and Stocks to Consider</h2>
Green Dot currently carries a Zacks Rank #3 (Hold).
Investors interested in the Zacks&nbsp;Business Services&nbsp;sector may also look at Docusign (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>) and AppLovin (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/app#NASDAQ">APP</a>).
Docusign flaunts a Zacks Rank #1 (Strong Buy) at present. It has a long-term earnings growth expectation of 9.3%.
DOCU delivered a trailing four-quarter earnings surprise of 18.3%, on average.
AppLovin sports a Zacks Rank #1 at present. It has a long-term earnings growth expectation of 20%.APP delivered a trailing four-quarter earnings surprise of 21.1%, on average.
<a href="https://www.zacks.com/stock/news/2338736/why-you-should-retain-green-dot-stock-in-your-portfolio-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2338736">To read this article on Zacks.com click here.</a>

Large Cap

Dividends

Small Cap

Federal Reserve

DOCU

GDOT

Why You Should Retain Green Dot Stock in Your Portfolio for Now

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2024/09/2024-09-20_08h35_26-1.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h3 class="wp-block-heading">Nuclear Power Revival</h3>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-quad-witching-nuclear-power-revival-ceg-mc-09202024">click here</a> for an enlarged chart of Constellation Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of CEG is being used to illustrate the point.</li>
<li>To feed the power hungry AI data centers, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is signing a power purchase agreement with CEG.</li>
<li>The chart shows the gap up on CEG news.</li>
<li>The chart shows that CEG is in the resistance zone.</li>
<li>RSI on the chart shows that CEG is very overbought.&nbsp; An overbought stock tends to pullback.</li>
<li>Based on the quantitative screen of The Arora Report's ZYX Change Method, CEG is way overvalued at this time.&nbsp; However, CEG will benefit from AI, and as such, it is on our radar to give a signal when it is appropriate.</li>
<li>To provide the power, CEG will restart Three Mile Island Unit 1.&nbsp; This reactor was shut down about five years ago due to economic reasons.&nbsp; Three Mile Island Unit 2 is famous for a partial melt down, which caused the most serious nuclear accident on U.S. soil.&nbsp; In addition to CEG, there are opportunities in other energy producers that will help meet the massive power demand for AI.
<ul>
<li>Quanta Services Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) is a contractor to electric utilities and is benefiting from the AI power demand.&nbsp; As full disclosure, PWR is in The Arora Report&#8217;s ZYX Buy Core Model Portfolio. PWR is long from $37.&nbsp; </li>
<li>First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), which provides solar power to data centers. As full disclosure, FSLR is in The Arora Report&#8217;s ZYX Buy Core Model Portfolio.</li>
<li>A new name that is on The Arora Report&#8217;s radar is Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>). As full disclosure, a signal may be given when appropriate.</li>
</ul>
</li>
<li>We shared with readers yesterday that quad witching was to the upside.
<ul>
<li>A part of the strength in the stock market yesterday was due to quad witching and not due to the Fed's 50 bps interest rate cut.</li>
<li>About $5 trillion notional value of stock derivatives are expiring today.&nbsp; This is a huge amount but not a record.</li>
<li>This morning, expiring futures are exerting downward pressure on the market after yesterday's runup.&nbsp; Futures are expiring this morning.</li>
<li>Options will expire in the afternoon.</li>
</ul>
</li>
<li>Historically, gains due to quad witching tend to reverse in the following week and sometimes even on the expiration day.</li>
</ul>
<h3 class="wp-block-heading">Japan</h3>
In a relief to U.S. stock investors, the Bank of Japan (BOJ) left interest rates unchanged.
<h3 class="wp-block-heading">Magnificent Seven Money Flows</h3>
In the early trade, money flows are positive in Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>).
In the early trade, money flows are neutral in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and MSFT.
In the early trade, money flows are negative in NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are negative in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).  The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).  The most popular ETF for oil is United States Oil ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>).
<h3 class="wp-block-heading">Bitcoin</h3>
Trump's advocacy continues to bring buying into Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). Here is the key question: Will bitcoin whales take advantage of the strength to sell as is their pattern?
<h3 class="wp-block-heading">Protection Band And What To Do Now</h3>
It is important for investors to look ahead and not in the rearview mirror.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h3 class="wp-block-heading">Traditional 60/40 Portfolio</h3>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

$BTC

AAPL

AMZN

FSLR

GOOG

NVDA

TSLA

$5 Trillion Worth Of Quad Witching, AI Leading To Revivial Of Nuclear Power

JMP Securities analyst Trevor Walsh reiterates Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) with a Market Outperform and maintains $4 price target.

JMP Securities Reiterates Market Outperform on Planet Labs, Maintains $4 Price Target

Susquehanna analyst Mehdi Hosseini maintains Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) with a Positive and raises the price target from $46 to $55.

Susquehanna Maintains Positive on Corning, Raises Price Target to $55

Susquehanna analyst Bascome Majors maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Positive and lowers the price target from $345 to $330.

Susquehanna Maintains Positive on FedEx, Lowers Price Target to $330

iPower shares are trading lower after the company reported worse-than-expected Q4 revenue results.

Susquehanna analyst James Friedman maintains Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Positive and lowers the price target from $66 to $55.

DAVA

Susquehanna Maintains Positive on Endava, Lowers Price Target to $55

Susquehanna analyst James Friedman initiates coverage on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Positive rating and announces Price Target of $52.

Initiation

AFRM

Susquehanna Initiates Coverage On Affirm Holdings with Positive Rating, Announces Price Target of $52

JMP Securities analyst Silvan Tuerkcan reiterates Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) with a Market Outperform and maintains $29 price target.

EXEL

JMP Securities Reiterates Market Outperform on Exelixis, Maintains $29 Price Target

PBF Energy shares are trading lower after Piper Sandler downgraded the stock from Neutral to Underweight and lowered its price target from $47 to $25.

Macro Economic Events

Market Summary

Economics

Benzinga Market Summary: FedEx Falls After Q1 Earnings, Constellation Energy Rises With Microsoft Deal, Trump Media & Technology Group Lockup Period Expires

Cyclo Therapeutics reports Q1 results

The Limitations Of Anti-Inflammatory Drugs For The Treatment Of Alzheimer's Disease

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Springworks Therapeutics (SWTX – Research Report), C...

Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Cyclo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyth-stock-quote/">CYTH</a>) just reported results for the second quarter of 2024.<ul><li>Cyclo Therapeutics reported earnings per share of -21 cents. This was below the analyst estimate for EPS of -15 cents.</li><li>The company reported revenue of $123,104.</li><li>This was 54.41% worse than the analyst estimate for revenue of $270,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/cyth-stock-earnings-cyclo-therapeutics-for-q2-of-2024/">CYTH Stock Earnings: Cyclo Therapeutics Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CYTH Stock Earnings: Cyclo Therapeutics Misses EPS, Misses Revenue for Q2 2024

Cyclo Therapeutics reports Q2 results

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Cyclo Therapeutics (CYTH – Research Report), wit...

Cyclo Therapeutics: A Buy Rating with Significant Upside Potential Based on Clinical Progress and Financial Projections

Maxim Group analyst Jason McCarthy maintained a Buy rating on Cyclo Therapeutics (CYTH – Research Report) yesterday and set a price target of $4.00...

Optimistic Buy Rating for Cyclo Therapeutics Amidst Promising Clinical Trials and Financial Prospects

Cyclo Therapeutics falls after merger agreement with Rafael Holdings

Cyclo Therapeutics (CYTH) has issued an update. Cyclo Therapeutics, Inc. has entered into a Merger Agreement with Rafael Holdings, Inc., which will...

Cyclo Therapeutics' Merger and Financial Arrangements with Rafael Holdings

In a report released today, Swayampakula Ramakanth from H.C. Wainwright downgraded Cyclo Therapeutics (CYTH – Research Report) to a Hold, with a pr...

Cyclo Therapeutics Acquisition by Rafael Holdings: A Revised Hold Rating and Price Target Adjustment

ALEC

AVXL

BIVI

COYA

CYTHW

INMB

ONCT

SWTX

Press Releases

CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders

Penny Stocks

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc. - CYTH

Shareholder Alert: Ademi LLP investigates whether Cyclo Therapeutics, Inc. has obtained a Fair Price for its Public Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders

Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CYTH, ARCH, CEIX on Behalf of Shareholders

CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, ARCH, CYTH on Behalf of Shareholders

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Cyclo Therapeutics

Cyclo Therapeutics (CYTH) Forecast

Cyclo Therapeutics (NASDAQ:CYTH) Stock, Quote.Headers.trade-ideas